Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173,192 | 124,429 | 144,389 | 164,278 | 45,083 |
| Other current assets | 2,000 | 2,000 | 2,000 | 2,000 | 0 |
| TOTAL | $178,470 | $130,597 | $149,868 | $171,807 | $54,115 |
| Non-Current Assets | |||||
| PPE Net | 10,513 | 10,686 | 10,826 | 11,169 | 14,139 |
| Other Non-Current Assets | 11,410 | 11,716 | 12,037 | 12,793 | 13,289 |
| TOTAL | $21,923 | $22,402 | $22,863 | $23,962 | $27,428 |
| Total Assets | $200,393 | $152,999 | $172,731 | $195,769 | $81,543 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,718 | 10,380 | 6,366 | 7,520 | 10,766 |
| Accrued Expenses | 11,875 | 13,562 | 12,284 | 13,638 | 19,632 |
| Other current liabilities | N/A | N/A | N/A | 140,534 | N/A |
| TOTAL | $34,176 | $38,637 | $36,756 | $180,451 | $50,641 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,835 | 40,512 | 40,508 | 38,548 | 38,354 |
| Deferred Revenues | 13,583 | 14,695 | 18,106 | 18,759 | 20,243 |
| Other Non-Current Liabilities | 19,514 | 20,001 | 20,530 | 22,933 | 23,450 |
| TOTAL | $57,349 | $60,513 | $61,038 | $64,432 | $68,016 |
| Total Liabilities | $91,525 | $99,150 | $97,794 | $244,883 | $118,657 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 204,943 | 187,018 | 187,018 | 186,960 | 64,465 |
| Common Shares | 2 | 2 | 2 | 2 | 1 |
| Retained earnings | -557,996 | -537,068 | -513,007 | -560,748 | -443,661 |
| Other shareholders' equity | 2,405 | -251 | 0 | 0 | 0 |
| TOTAL | $108,868 | $53,849 | $74,937 | $-49,114 | $-37,114 |
| Total Liabilities And Equity | $200,393 | $152,999 | $172,731 | $195,769 | $81,543 |